Search

Your search keyword '"Norris MD"' showing total 360 results

Search Constraints

Start Over You searched for: Author "Norris MD" Remove constraint Author: "Norris MD"
360 results on '"Norris MD"'

Search Results

1. A systematic review of quality and consistency of clinical practice guidelines on the primary prevention of food allergy and atopic dermatitis

2. The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis.

3. FDA-approved disulfiram as a novel treatment for aggressive leukemia.

4. Reoperation and Complication Rates Following Patellar Fracture Repair with Plates

6. The induced membrane technique for bone defects: Basic science, clinical evidence, and technical tips

7. Church Attendance and Mobility Limitation Among Black and White Men With Prostate Cancer

9. Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma.

10. Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma.

11. Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia.

12. Potential of Membranes Surrounding the Fetus as Immunoprotective Cell-Carriers for Allogeneic Transplantations

14. Solid Pseudopapillary Neoplasm: A Single Institutional Case Series of a Rare Pancreatic Tumor

15. Solid Pseudopapillary Neoplasm: A Single Institutional Case Series of a Rare Pancreatic Tumor

16. In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer

17. Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma

18. The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression

19. Suppression of the ABCA1 Cholesterol Transporter Impairs the Growth and Migration of Epithelial Ovarian Cancer

20. Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.

21. Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia

22. A Primer for Assessing the Pathology in Mouse Models of Neuroblastoma

23. Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma

24. Dual targeting of chromatin stability by the curaxin CBL0137 and histone deacetylase inhibitor panobinostat shows significant preclinical efficacy in neuroblastoma

25. Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin

26. A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma

27. Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas

28. Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG

29. Targeted therapy of TERT-rearranged neuroblastoma with BET bromodomain inhibitor and proteasome inhibitor combination therapy

30. Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy

31. Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy

32. Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer

33. Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia

34. Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition

35. CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth

36. Targeting TSLP-induced tyrosine kinase signaling pathways in CRLF2-Rearranged Ph-like ALL

37. Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia

38. OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis

39. ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancer

40. PRECISION MEDICINE FOR PAEDIATRIC HIGH-GRADE DIFFUSE MIDLINE GLIOMAS - RESULTS FROM THE ZERO CHILDHOOD CANCER COMPREHENSIVE PRECISION MEDICINE PROGRAM

45. A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction

46. Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma

47. Macrophage-derived IL1B and TNFa regulate arginine metabolism in neuroblastoma

48. Drugging MYCN oncogenic signaling through the MYCN-PA2G4 binding interface

49. The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35

50. JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis

Catalog

Books, media, physical & digital resources